Senior Program Manager; SPM), Immunology Medical Evidence Generation; MEG​/Cycle Management

Job title: Senior Program Manager (SPM), Immunology Medical Evidence Generation (MEG)/Life Cycle Management (LCM)

Location: Cambridge, MA

Grade: L3-1

Hiring Manager: Michael Floriani

This individual provides program/project management expertise and operational support for complex, Immunology Franchise focused medical evidence generation strategies in partnership with the respective TA Lifecycle Management Medical Heads across the alliance immunology franchise.

The Medical Evidence Generation SPM will help drive the strategic direction and seamless operational execution of the evidence generation portfolio objectives supporting the business-related initiatives for the Alliance Immunology Franchise. This individual will work closely with his/her respective Medical Program Lead (MPL) and TA Global Medical Teams (GMT) across immunology, both internally and with our collaborative Alliance partners to define and organize the operational execution aspects of Evidence Generation LCM-related initiatives.

The individual in this role, while working in a matrix team of people and resources, will support the Medical Program Lead and GMT to ensure alignment of key activities outlined in the Global Medical Plans to implement and execute Integrated Evidence Generation Strategies (IEGPs). The medical evidence generation SPM will be entrenched in the cross-functional strategy to define evidence generation goals and objectives for each indication-specific aspect of Immunology Alliance products to ensure that the Integrated Evidence Generation Plans (IEGPs) align with the overall strategy of the Immunology Franchise.

This role will also communicate on a defined cadence as well as ad hoc basis reporting regarding the status of evidence generation activities to leadership, across the Immunology franchise and beyond when applicable with alliance partners to better inform specific to the decision‑making processes.

Join the engine of Sanofis mission where deep immunoscience meets bold, AI‑powered research. In R&D, youll drive breakthroughs that could turn the impossible into possible for millions.

Were an R&D‑driven, AI‑powered biopharma company committed to improving peoples lives and delivering compelling growth. Our deep understanding of the immune system and innovative pipeline enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve peoples lives.

• Support building and execution of the Global Medical Affairs strategy and plan for Dupilumab as it relates to Integrated Evidence Generation Planning (IEGP).
• Work collaboratively with LCM Leads to ensure synergy of activities for Integrated Evidence Generation Plan (IEGP) development and associated financial planning.
• Ensure that a Glocal approach is taking as it relates to country inclusion and exchange for data gap identification and prioritization within the evidence generation life cycle management. Facilitating a true two‑way interaction between the local entities and global medical stakeholders.
• Implement and execute strategic operational aspects of the Medical Evidence Generation plans across the dupilumab franchise, this includes data gap generation and prioritization, Medical Brand Planning, IEGP implementation and maintenance, and insight into the appropriate financial documentation. Ensuring that both medical and financial strategic planning align for long range forecasting efforts.
• Coordinate the evidence generation insights throughout the network of affiliate Medical Directors through regular contacts and meetings ensuring all relevant aspects of the evidence portfolio development is aligned across the G10 countries and beyond.
• Collaborate with alliance partners at Regeneron; take a team‑oriented approach to making sure evidence strategy is clearly defined and consistent with relevant stakeholders in Research and Clinical Development.
• Coordinate consistent communication, alignment and workshopping across cross‑functional partners including HEVA, Market Access and Translational.
• Communicate consistent strategy and evidence…